New insights into the pathophysiology of inflammatory bowel disease: microbiota, epigenetics and common signalling pathways

The exact pathophysiology of inflammatory bowel disease is still unknown. However, over the years important insights allowed the development of novel therapeutic approaches that are at the threshold of introduction into clinical practice, or at least in clinical trials.